Publication | Closed Access

Genotrim™, a DNA-customized nutrigenomic product, targets genetic factors of obesity: Hypothesizing a dopamine–glucose correlation demonstrating reward deficiency syndrome (RDS)

ObesityMetabolic SyndromeNutritionDopamine–glucose CorrelationMetabolic DisorderDna-customized Nutrigenomic ProductMedicineGeneticsGenetic EpidemiologyMolecular NutritionGenetic FactorReward Deficiency SyndromePublic HealthPharmacologyMetabolic Health